Sameh Hozayen

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 4

Top Topics

Acute Kidney Injury

Inflammatory Response

Vascular Smooth Muscle Cells

Idiopathic Pulmonary Fibrosis

Top Venues

Annals of internal medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Sarah Alabsi, Atharva Dhole, Sameh Hozayen, Scott A Chapman
Angiotensin-Converting Enzyme 2 Expression and Severity of SARS-CoV-2 Infection. Microorganisms 11 (3) (2023)
Sarah Alabsi, Atharva Dhole, Sameh Hozayen, Scott A Chapman
Angiotensin-Converting Enzyme 2 Expression and Severity of SARS-CoV-2 Infection. Microorganisms 11 (3) (2023)
Sarah Alabsi, Atharva Dhole, Sameh Hozayen, Scott A Chapman
Angiotensin-Converting Enzyme 2 Expression and Severity of SARS-CoV-2 Infection. Microorganisms 11 (3) (2023)
Gail E Potter, Tyler Bonnett, Kevin B Rubenstein, David A Lindholm, Rekha R Rapaka, Sarah B Doernberg, David Chien Boon Lye, Richard A Mularski, Noreen A Hynes, Susan Kline, Catharine I Paules, Cameron R Wolfe, Maria G Frank, Nadine G Rouphael, Gregory A Deye, Daniel A Sweeney, Rhonda E Colombo, Richard T Davey, Aneesh K Mehta, Jennifer A Whitaker, Jose G Castro, Alpesh N Amin, Christopher J Colombo, Corri B Levine, Mamta K Jain, Ryan C Maves, Mahomed-Yunus Moosa, Robert Grossberg, Sameh Hozayen, Timothy H Burgess, Robert L Atmar, Anuradha Ganesan, Carlos A Gomez, Constance A Benson, Diego Lopez de Castilla, Neera Ahuja, Sarah L George, Seema U Nayak, Stuart H Cohen, Tahaniyat Lalani, William R Short, Nathaniel Erdmann, Kay M Tomashek, Pablo Tebas
Temporal Improvements in COVID-19 Outcomes for Hospitalized Adults: A Post Hoc Observational Study of Remdesivir Group Participants in the Adaptive COVID-19 Treatment Trial. Annals of internal medicine (2022)